Home > News > Carbon Nanotubes Pass Safety Test
February 14th, 2006
Carbon Nanotubes Pass Safety Test
Abstract:
A new study could allay some of the fears about health and safety issues relating to carbon nanotubes and open the door for exploring the use of such nanomaterials in the body. "This is the first time carbon nanotubes have been administered intravenously and fundamental pharmacokinetic parameters have been obtained," Kostarelos tells C&EN. "It is also the first description of carbon nanotubes circulating in the blood of live animals and the first report showing blood clearance and urine excretion of the nanotubes."
Source:
Chemical & Engineering News
Bookmark:
| Related News Press |
Preparing for Nano
Disruptive by Design: Nano Now February 1st, 2019
How nanoscience will improve our health and lives in the coming years: Targeted medicine deliveries and increased energy efficiency are just two of many ways October 26th, 2016
Searching for a nanotech self-organizing principle May 1st, 2016
Nanotubes/Buckyballs/Fullerenes/Nanorods/Nanostrings
Enhancing power factor of p- and n-type single-walled carbon nanotubes April 25th, 2025
Chainmail-like material could be the future of armor: First 2D mechanically interlocked polymer exhibits exceptional flexibility and strength January 17th, 2025
Innovative biomimetic superhydrophobic coating combines repair and buffering properties for superior anti-erosion December 13th, 2024
Announcements
Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025
Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025
Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025
ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||